Evidence map›Paper›PMID 28215999›Full record

ReviewNeuropharmacology2017

Rat animal models for screening medications to treat alcohol use disorders.

Richard L Bell, Sheketha R Hauser, Tiebing Liang, Youssef Sari, Antoniette Maldonado-Devincci, Zachary A Rodd

Open access · greenAbstract readReview
In one paragraph

Review in Neuropharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Neuroimaging in alcohol use disorder: From mouse to man.Journal of neuroscience research · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. FACTORS CONTRIBUTING TO THE ESCALATION OF ALCOHOL CONSUMPTION.Neuroscience and biobehavioral reviews · 2022
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Richard L BellIndiana University School of Medicine, Department of Psychiatry, Indianapolis, IN 46202, USA. Electronic address: ribell@iupui.edu.
Sheketha R HauserIndiana University School of Medicine, Department of Psychiatry, Indianapolis, IN 46202, USA.
Tiebing LiangIndiana University School of Medicine, Department of Gastroenterology, Indianapolis, IN 46202, USA.
Youssef SariUniversity of Toledo, Department of Pharmacology, Toledo, OH 43614, USA.
Antoniette Maldonado-DevincciNorth Carolina Agricultural and Technical State University, Department of Psychology, Greensboro, NC 27411, USA.
Zachary A RoddIndiana University School of Medicine, Department of Psychiatry, Indianapolis, IN 46202, USA.
Indiana University School of MedicineNorth Carolina Agricultural and Technical State University · USUniversity of Toledo · US

Funding

RAT RESEARCH COMPONENTP50AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CRABB, DAVID W · 1987 to 2002
$5.3M
Rodents with Genetic Differences in Alcohol PreferenceR24AA015512 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BELL, RICHARD LOWELL · 2005 to 2014
$5.1M
Rat Animal Models Core (RAMC)U01AA013522 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BELL, RICHARD LOWELL · 2001 to 2014
$4.3M
Rodents with Genetic Differences in Alcohol PreferenceU24AA015512 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI BELL, RICHARD LOWELL · 2015 to 2019
$2.7M
Rat Animal Models & Drug and Gene Testing Core (RAM-DGTC)U24AA013522 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI BELL, RICHARD LOWELL · 2015 to 2021
$2.4M
Consequences of voluntary intake of ethanol & nicotine during peri-adolescenceR01AA020396 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI BELL, RICHARD LOWELL, ENGLEMAN, ERIC A. · 2012 to 2016
$1.2M
NIAAA NIH HHS P50 AA007611NIAAA NIH HHS R01 AA020396NIAAA NIH HHS R24 AA015512NIAAA NIH HHS U01 AA013522NIAAA NIH HHS U24 AA013522NIAAA NIH HHS U24 AA015512
6 · The paper itself

Abstract

The purpose of this review is to present animal research models that can be used to screen and/or repurpose medications for the treatment of alcohol abuse and dependence. The focus will be on rats and in particular selectively bred rats. Brief introductions discuss various aspects of the clinical picture, which provide characteristics of individuals with alcohol use disorders (AUDs) to model in animals. Following this, multiple selectively bred rat lines will be described and evaluated in the context of animal models used to screen medications to treat AUDs. Next, common behavioral tests for drug efficacy will be discussed particularly as they relate to stages in the addiction cycle. Tables highlighting studies that have tested the effects of compounds using the respective techniques are included. Wherever possible the Tables are organized chronologically in ascending order to describe changes in the focus of research on AUDs over time. In general, high ethanol-consuming selectively bred rats have been used to test a wide range of compounds. Older studies usually followed neurobiological findings in the selected lines that supported an association with a propensity for high ethanol intake. Most of these tests evaluated the compound's effects on the maintenance of ethanol drinking. Very few compounds have been tested during ethanol-seeking and/or relapse and fewer still have assessed their effects during the acquisition of AUDs. Overall, while a substantial number of neurotransmitter and neuromodulatory system targets have been assessed; the roles of sex- and age-of-animal, as well as the acquisition of AUDs, ethanol-seeking and relapse continue to be factors and behaviors needing further study. This article is part of the Special Issue entitled "Alcoholism".

Indexed as

Disease Models, AnimalAlcohol DrinkingAlcoholismAnimalsBehavior, AnimalBinge DrinkingDrug Evaluation, PreclinicalDrug-Seeking BehaviorEthanolRatsEthanolAAAcamprosate (PubChem CID: 71158)AlcoholismAlcohol use disorderBaclofen (PubChem CID: 2284)Ceftriaxone (PubChem CID: 5479530)Ethanol (PubChem CID: 702)Family history positiveFluoxetine (PubChem CID: 3386)Genetically predisposedHADmsPNaltrexone (PubChem CID: 5360515)PPharmacotherapyPrazosin (PubChem CID: 4893)Rolipram (PubChem CID: 5092)Selectively bredsPTopiramate (PubChem CID: 5284627)UChBVarenicline (PubChem CID: 5310966)WHP

Identifiers

PMID28215999
PMCPMC5659204
OpenAlexW2588838027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.